RESEARCH-USE BIOSIMILAR ANTIBODY
Rulonilimab
Monoclonal antibody · IgG1
Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity.
TARGETPDCD1
YMonoclonal antibody
CATALOGSC-BS-194
CATALOG NUMBERSC-BS-194
MOLECULAR WEIGHTApprox. 145.78 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity.
Rulonilimab is a recombinant research-use antibody directed against PDCD1.